Biostar Pharmaceuticals, Inc.: 10-Q filed 2013-08-19
What Biostar Pharmaceuticals, Inc. reported in its quarterly report filed 2013-08-19 (fiscal Q2 2013): 33 published measures, 90 facts as tagged in accession 0001185185-13-001862.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2013-08-19
- Fiscal period
- fiscal Q2 2013
- Accession
- 0001185185-13-001862 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All Biostar Pharmaceuticals, Inc. filings.
Reported measures
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 60,351,077 | USD | |
| At 2012-12-31 | 57,772,748 | USD | |
| At 2011-12-31 | 76,401,700 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 9,951,153 | USD | |
| At 2012-12-31 | 1,759,078 | USD | |
| At 2012-06-30 | 18,709,594 | USD | |
| At 2011-12-31 | 16,971,789 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | -730,980 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -170,006 | USD | 181 |
| 2012-01-01 to 2012-12-31 | -19,997,323 | USD | 366 |
| 2012-04-01 to 2012-06-30 | -9,482,552 | USD | 91 |
| 2012-01-01 to 2012-06-30 | -7,315,137 | USD | 182 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-06-30 | 10,477,322 | USD | 181 |
| 2012-01-01 to 2012-06-30 | 2,723,549 | USD | 182 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-06-30 | 4,378 | USD | 181 |
| 2012-01-01 to 2012-06-30 | 13,819 | USD | 182 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-06-30 | -1,601,614 | USD | 181 |
| 2012-01-01 to 2012-06-30 | -791,176 | USD | 182 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-06-30 | -955,052 | USD | 181 |
| 2012-01-01 to 2012-06-30 | -282,116 | USD | 182 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 23,059,737 | USD | |
| At 2012-12-31 | 23,229,743 | USD |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | 168,766 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 696,351 | USD | 181 |
| 2012-04-01 to 2012-06-30 | -2,676,180 | USD | 91 |
| 2012-01-01 to 2012-06-30 | -1,574,864 | USD | 182 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 7,876,513 | USD | |
| At 2012-12-31 | 6,980,521 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-06-30 | 6,147 | USD | 181 |
| 2012-01-01 to 2012-06-30 | 71,358 | USD | 182 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | -794,732 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -63,618 | USD | 181 |
| 2012-04-01 to 2012-06-30 | -12,237,837 | USD | 91 |
| 2012-01-01 to 2012-06-30 | -9,050,013 | USD | 182 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 41,446,531 | USD | |
| At 2012-12-31 | 41,974,131 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | 99,521 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 195,209 | USD | 181 |
| 2012-04-01 to 2012-06-30 | 17,099 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 32,134 | USD | 182 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 10,835,266 | USD | |
| At 2012-12-31 | 12,702,552 | USD |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 18,354,739 | USD | |
| At 2012-12-31 | 9,136,439 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 13,478,205 | USD | |
| At 2012-12-31 | 21,851,412 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | 7,674,182 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 13,631,958 | USD | 181 |
| 2012-04-01 to 2012-06-30 | 16,810,842 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 24,459,409 | USD | 182 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 1,744,982 | USD | |
| At 2012-12-31 | 847,135 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | 6,879,450 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 13,568,340 | USD | 181 |
| 2012-04-01 to 2012-06-30 | 4,573,005 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 15,409,396 | USD | 182 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | 805,613 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 1,601,614 | USD | 181 |
| 2012-04-01 to 2012-06-30 | 789,776 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 1,580,903 | USD | 182 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 11,596,113 | shares | |
| At 2012-12-31 | 9,993,549 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 24,633,499 | USD | |
| At 2012-12-31 | 23,266,776 | USD |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 5,908,877 | USD | |
| At 2012-12-31 | 4,528,868 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 10,107,971 | USD | |
| At 2012-12-31 | 8,957,813 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 2,231,458 | USD | |
| At 2012-12-31 | 1,977,292 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 18,354,739 | USD | |
| At 2012-12-31 | 9,136,439 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 5,635,737 | USD | |
| At 2012-12-31 | 7,740,673 | USD |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | 211,196 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 1,210,003 | USD | 181 |
| 2012-04-01 to 2012-06-30 | -9,439,731 | USD | 91 |
| 2012-01-01 to 2012-06-30 | -7,016,856 | USD | 182 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | 1,458,818 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 2,536,566 | USD | 181 |
| 2012-04-01 to 2012-06-30 | 1,383,843 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 2,484,549 | USD | 182 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | 232,518 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 589,963 | USD | 181 |
| 2012-04-01 to 2012-06-30 | 79,105 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 160,012 | USD | 182 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-06-30 | -8,736,339 | USD | 181 |
| 2012-01-01 to 2012-06-30 | -3,727,917 | USD | 182 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-06-30 | 871,434 | USD | 181 |
| 2012-01-01 to 2012-06-30 | -535,421 | USD | 182 |
Inspect the source
- Entity
- Biostar Pharmaceuticals, Inc. / CIK 0001418133
- Captured
- SEC response SHA-256
65bfcb22925fcd8d50013fde5b00c59d0adcec0a6e09b2504502010fb5944726
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001418133.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))